Matthew Redihan

Allison Dorval is the Chief Financial Officer of Verve Therapeutics. Ms. Dorval is an experienced financial executive with more than 20 years of leadership experience in finance, accounting and investor relations. Prior to joining Verve, she served as Chief Financial Officer at Voyager Therapeutics. She is a member of the Board of Directors at Aerovate Therapeutics and Puma Biotechnology. Ms. Dorval previously served as vice president and controller at Juniper Pharmaceuticals, Inc., and as Chief Financial Officer at Insulet Corporation. Ms. Dorval also held corporate finance positions with iBasis, Inc. and Digitas Inc. She is a certified public accountant and began her career in public accounting at PricewaterhouseCoopers LLP. Ms. Dorval obtained a Bachelor of Science in Business Administration from the University of Vermont.